干细胞之家 - 中国干细胞行业门户第一站

 

 

搜索
中源协和

免疫细胞治疗专区

欢迎关注干细胞微信公众号

  
查看: 13694|回复: 1
go

颌骨组织工程 [复制链接]

Rank: 1

积分
34 
威望
34  
包包
206  
楼主
发表于 2011-5-13 15:23 |只看该作者 |倒序浏览 |打印
颌骨的再生修复
附件: 你需要登录才可以下载或查看附件。没有帐号?注册
已有 1 人评分威望 包包 收起 理由
细胞海洋 + 1 + 5

总评分: 威望 + 1  包包 + 5   查看全部评分

Rank: 1

积分
威望
5  
包包
104  
沙发
发表于 2012-4-5 10:58 |只看该作者
第一篇文,
" F; J  O5 C: |2 O4 L* K- ga b s t r a c t
" f& r% {0 |* S2 Y9 W% L# ~Premineralized silk fibroin protein scaffolds (mSS) were prepared to combine the osteoconductive properties of biological apatite with aqueous-derived silk scaffold (SS) as a composite scaffold for bone regeneration. The aim of present study was to evaluate the effect of premineralized silk scaffolds combined with bone morphogenetic protein-2 (BMP-2) modified bone marrow stromal cells (bMSCs) to repair mandibular bony defects in a rat model. bMSCs were expanded and transduced with adenovirus AdBMP-2, AdLacZ gene in vitro. These genetically modified bMSCs were then combined with premineralized silk scaffolds to form tissue-engineered bone. Mandibular repairs with AdBMP-2 transduced bMSCs/mSS constructs were compared with those treated with AdLacZ-transduced bMSCs/mSS constructs, native (non-transduced) bMSCs/mSS constructs and mSS alone. Eight weeks after post operation, the mandibles were explanted and evaluated by radiographic observation, micro-CT, histological analysis and immunohistochemistry. The presence of BMP-2 gene enhanced tissue-engineered bone in terms of the most new bone formed and the highest local bone mineral densities (BMD) found. These results demonstrated that premineralized silk scaffold could serve as a potential substrate for bMSCs to construct tissue-engineered bone for mandibular bony defects. BMP-2 gene therapy and tissue engineering techniques could be used in mandibular repair and bone regeneration.. C+ g- p" j$ V$ {
_ 2009 Elsevier Ltd. All rights reserved.
‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册
验证问答 换一个

Archiver|干细胞之家 ( 吉ICP备2021004615号-3 )

GMT+8, 2025-12-18 08:38

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.